Essential Wellness Pharma Recalls Dual Test Cyp/ena Injection Due to Sterility Concerns
Essential Wellness Pharma is recalling Dual Test Cyp/ena Injection vials because poor sterile production practices resulted in a lack of sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text identifies the recall as FDA Class II and cites a lack of sterility assurance, which poses a significant risk of serious health consequences such as infection, meeting the criteria for a Severe rating.
Plain-English summary
Kalman Health & Wellness, Inc. dba Essential Wellness Pharma is recalling all compounded sterile preparations of Dual Test Cyp/ena 1:1 200 mg/mL Injection. The recall includes 5 mL and 100 mL vials distributed nationwide. The specific lots affected are 060815, 061615, 062915, 070615, 071615, 073015, and 080615, with expiration dates ranging from September 2015 to November 2015.
The recall was initiated due to observations associated with poor sterile production practices. These practices resulted in a lack of sterility assurance for the finished drugs. The agency has classified this as a Class II recall.
Consumers and healthcare providers should stop using the affected products and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- DUAL TEST CYP/ENA 1:1 200 mg/mL Injection, packaged in a) 5 mL and b) 100 mL vials, Rx only, Essential Wellness PHARMACY, 4625 N. University, Peoria, IL 61614.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot #: 060815
- Exp 09/08/2015
- 061615
- Exp 09/16/2015
- 062915
- Exp 09/29/2015
- 070615
- Exp 10/06/2015
- 071615
- Exp 10/16/2015
- 073015
- Exp 10/30/2015
- and 080615
- Exp 11/08/2015
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 39 recalled by Kalman Health & Wellness, Inc. dba Essential Wellness Pharma under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 39 products in this recall →Related recalls
Same manufacturer · Kalman Health & Wellness, Inc. dba Essential Wellness Pharma
See all →- SevereEssential Wellness Pharma Recalls 17-Alpha Hydroxyprogesterone Injections for Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereEssential Wellness Pharma Recalls Sermorelin Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- Severe
- SevereEssential Wellness Pharma Recalls Dexamethasone Ointment Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereSermorelin Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-25
Same hazard · sterility failure
See all →- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereTransvenous Pacing Electrode Tray with Bipolar Balloon Pacing Electrode Recalled
FDA (Devices) · 2026-07-22
- SevereArterial Line Kit with Lidocaine HCL Injection Fails Sterility Testing
FDA (Devices) · 2026-07-22
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22